Late incidence and determinants of stroke after aortic and mitral valve replacement

Marc Ruel1, Roy G Masters, Fraser D Rubens

  • 1Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. mruel@ottawaheart.ca

Insights

Patients with prosthetic valves face a significant risk of embolic stroke, with approximately 20% experiencing one within 15 years. Modifiable factors like avoiding smoking and timely mitral valve surgery can reduce this risk.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Clinical Epidemiology

Background:

  • Stroke is a serious complication for patients with prosthetic heart valves.
  • Characterizing the long-term occurrence of stroke in this population from a large cohort is needed.

Purpose of the Study:

  • To investigate the incidence and risk factors of late stroke in patients following left-heart valve replacement.

Main Methods:

  • A prospective study followed 3,189 adult patients (3,576 valve replacement operations) for 20,096 patient-years.
  • Bootstrapped survival analysis identified patient and valve-related factors influencing stroke incidence.

Main Results:

  • Embolic strokes occurred at rates of 1.3-2.3% per year, with mitral mechanical valves having the highest incidence (2.3% +/- 0.4%).
  • Independent risk factors included age >75, female gender, smoking, atrial fibrillation, coronary disease, and preoperative left ventricular dysfunction for mitral prostheses.
  • Warfarin combined with aspirin or dipyridamole did not significantly reduce stroke risk in mechanical prosthesis recipients.

Conclusions:

  • About 20% of patients with prosthetic valves experience an embolic stroke within 15 years post-replacement.
  • Potentially modifiable risk factors include smoking cessation, choice of mitral mechanical prostheses, aortic tilting-disc valves, and timely mitral surgery before left ventricular dysfunction onset.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...